AbbVie says blood cancer drug fails late-stage trial-March 2024-www.financetom.com

AbbVie says blood cancer drug fails late-stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

AbbVie says blood cancer drug fails late-stage trial

Jun 16, 2025 6:25 AM

June 16 (Reuters) -

AbbVie ( ABBV ) said on Monday its treatment for a group of

blood cancers failed to meet the main goal of overall survival

in a late-stage trial.

Previous page： Here are the details about BlackBerry Key2 Next page： Hyderabad hosts maiden International Blockchain Congress

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Here are the details about BlackBerry Key2

Aug 5, 2018

It has now launched the 6GB RAM + 64GB internal memory BlackBerry KEY2 in India for Rs 42,990 -- essentially a successor to KEYOne and the only smartphone in the market that sports a physical QWERTY keyboard.

Hyderabad hosts maiden International Blockchain Congress

Aug 3, 2018

The maiden edition of the International Blockchain Congress (IBC) was kickstarted in Hyderabad earlier today, to put India on the global roadmap for adoption of this new-age technology across sectors.

Steve Jobs nearly kept Apple from inventing its most successful product —the iPhone

Aug 6, 2018

"Steve founded Apple on the belief that the power of human creativity can solve even the biggest challenges — and that the people who are crazy enough to think they can change the world are the ones who do," Apple CEO Tim Cook said in an email to employees on Thursday.

Apple iPhone chip supplier says virus will delay shipments

Aug 5, 2018

Taiwan Semiconductor Co. Ltd. said 80 percent of the fabrication tools affected by Friday's virus had been recovered by Sunday. TSMC expects full recovery on Monday.